Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

Clinical trial NCT06732245 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06732245
Sponsor: Biomed Industries, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity and Overweight

Start date: 2026-08-15
Primary completion: 2027-08-15
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.